Published in Calcif Tissue Int on May 09, 2013
Cadherin 11, a miR-675 target, induces N-cadherin expression and epithelial-mesenchymal transition in melasma. J Invest Dermatol (2014) 0.85
N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and osteoanabolic action. J Bone Miner Res (2015) 0.80
PS1/γ-Secretase-Mediated Cadherin Cleavage Induces β-Catenin Nuclear Translocation and Osteogenic Differentiation of Human Bone Marrow Stromal Cells. Stem Cells Int (2016) 0.75
Cadherin-11 endocytosis through binding to clathrin promotes cadherin-11-mediated migration in prostate cancer cells. J Cell Sci (2015) 0.75
The Effects of TiO2 Nanodot Films with RGD Immobilization on Light-Induced Cell Sheet Technology. Biomed Res Int (2015) 0.75
The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol (2004) 24.63
Identification of the haematopoietic stem cell niche and control of the niche size. Nature (2003) 18.17
Convergence of Wnt, beta-catenin, and cadherin pathways. Science (2004) 13.13
Regulation of cadherin-mediated adhesion in morphogenesis. Nat Rev Mol Cell Biol (2005) 9.27
Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis. Endocr Rev (2000) 6.42
Regulation of cadherin adhesive activity. J Cell Biol (2000) 5.63
Regulation of bone mass by Wnt signaling. J Clin Invest (2006) 5.59
Stem cell niches in the adult mouse heart. Proc Natl Acad Sci U S A (2006) 4.58
Balancing cell adhesion and Wnt signaling, the key role of beta-catenin. Curr Opin Genet Dev (2005) 3.79
Developmental defects in mouse embryos lacking N-cadherin. Dev Biol (1997) 3.39
Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. Genes Dev (2000) 3.17
The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr Opin Cell Biol (2005) 3.09
Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb Perspect Biol (2010) 3.02
Cadherins. Annu Rev Cell Biol (1992) 2.79
A role for cadherins in tissue formation. Development (1996) 2.32
Transforming growth factor-beta-mediated chondrogenesis of human mesenchymal progenitor cells involves N-cadherin and mitogen-activated protein kinase and Wnt signaling cross-talk. J Biol Chem (2003) 2.25
Adhesion signaling: how beta-catenin interacts with its partners. Curr Biol (2001) 2.12
beta-Catenin: a pivot between cell adhesion and Wnt signalling. Curr Biol (2005) 2.06
The structural and functional analysis of cadherin calcium-dependent cell adhesion molecules. Curr Opin Cell Biol (1993) 2.03
DE-cadherin-mediated cell adhesion is essential for maintaining somatic stem cells in the Drosophila ovary. Proc Natl Acad Sci U S A (2002) 1.95
Molecular architecture of adherens junctions. Curr Opin Cell Biol (2001) 1.94
Wnt signaling and osteoblastogenesis. Rev Endocr Metab Disord (2006) 1.94
Expression and functional involvement of N-cadherin in embryonic limb chondrogenesis. Development (1994) 1.91
Phospho-regulation of Beta-catenin adhesion and signaling functions. Physiology (Bethesda) (2007) 1.89
Cdh1 regulates osteoblast function through an APC/C-independent modulation of Smurf1. Mol Cell (2011) 1.87
Transcription factors controlling osteoblastogenesis. Arch Biochem Biophys (2008) 1.85
Cadherin-mediated cellular signaling. Curr Opin Cell Biol (2003) 1.80
Regulation of osteoblast formation and function. Rev Endocr Metab Disord (2001) 1.80
Cables links Robo-bound Abl kinase to N-cadherin-bound beta-catenin to mediate Slit-induced modulation of adhesion and transcription. Nat Cell Biol (2007) 1.76
Tumor necrosis factor-alpha and interleukin-1beta increase the Fas-mediated apoptosis of human osteoblasts. J Lab Clin Med (1999) 1.73
Molecular cloning and characterization of OB-cadherin, a new member of cadherin family expressed in osteoblasts. J Biol Chem (1994) 1.70
Activity of the beta-catenin phosphodestruction complex at cell-cell contacts is enhanced by cadherin-based adhesion. J Cell Biol (2009) 1.57
Adhesion molecule signalling: not always a sticky business. Nat Rev Mol Cell Biol (2011) 1.55
The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J Clin Invest (1995) 1.53
Cell-cell communication in the osteoblast/osteocyte lineage. Arch Biochem Biophys (2008) 1.52
Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis. J Cell Sci (2004) 1.49
N-cadherin in osteolineage cells is not required for maintenance of hematopoietic stem cells. Blood (2012) 1.33
Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells. Blood (2012) 1.30
Human osteoblasts express a repertoire of cadherins, which are critical for BMP-2-induced osteogenic differentiation. J Bone Miner Res (1998) 1.30
Chondrogenic differentiation of murine C3H10T1/2 multipotential mesenchymal cells: II. Stimulation by bone morphogenetic protein-2 requires modulation of N-cadherin expression and function. Differentiation (1999) 1.27
Analysis of N-cadherin function in limb mesenchymal chondrogenesis in vitro. Dev Dyn (2002) 1.27
N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation. Mol Cell Biol (2008) 1.27
N-cadherin and cadherin 11 modulate postnatal bone growth and osteoblast differentiation by distinct mechanisms. J Cell Sci (2010) 1.26
Non-canonical Wnt signaling and N-cadherin related beta-catenin signaling play a role in mechanically induced osteogenic cell fate. PLoS One (2009) 1.26
Cadherin 11 expression marks the mesenchymal phenotype: towards new functions for cadherins? Cell Adhes Commun (1995) 1.25
N-cadherin is not essential for limb mesenchymal chondrogenesis. Dev Dyn (2005) 1.22
Mechanism of cell-cell adhesion complex assembly. Curr Opin Cell Biol (1999) 1.16
The transition of cadherin expression in osteoblast differentiation from mesenchymal cells: consistent expression of cadherin-11 in osteoblast lineage. J Bone Miner Res (2001) 1.13
Relative abundance of different cadherins defines differentiation of mesenchymal precursors into osteogenic, myogenic, or adipogenic pathways. J Cell Biochem (2000) 1.10
Cell-cell adhesion and signaling through cadherins: connecting bone cells in their microenvironment. J Bone Miner Res (2006) 1.08
Signaling pathways affecting skeletal health. Curr Osteoporos Rep (2012) 1.07
A dominant negative cadherin inhibits osteoblast differentiation. J Bone Miner Res (2000) 1.06
Accentuated ovariectomy-induced bone loss and altered osteogenesis in heterozygous N-cadherin null mice. J Bone Miner Res (2006) 1.05
N-CAM and N-cadherin expression during in vitro chondrogenesis. Exp Cell Res (1994) 1.04
Cell-cell interaction mediated by cadherin-11 directly regulates the differentiation of mesenchymal cells into the cells of the osteo-lineage and the chondro-lineage. J Bone Miner Res (2004) 1.03
Sp1/Sp3 and the myeloid zinc finger gene MZF1 regulate the human N-cadherin promoter in osteoblasts. Exp Cell Res (2005) 1.03
Role of N-cadherin and protein kinase C in osteoblast gene activation induced by the S252W fibroblast growth factor receptor 2 mutation in Apert craniosynostosis. J Bone Miner Res (2001) 1.01
Adhesive subdivisions intrinsic to the epithelial somites. Dev Biol (1999) 1.01
A role for N-cadherin in the development of the differentiated osteoblastic phenotype. J Bone Miner Res (2000) 1.00
Fibroblast growth factor-2 (FGF-2) increases N-cadherin expression through protein kinase C and Src-kinase pathways in human calvaria osteoblasts. J Cell Biochem (2001) 1.00
Role of N-cadherin in bone formation. J Cell Physiol (2002) 0.99
Alterations in the spatiotemporal expression pattern and function of N-cadherin inhibit cellular condensation and chondrogenesis of limb mesenchymal cells in vitro. J Cell Biochem (2002) 0.98
N-cadherin negatively regulates osteoblast proliferation and survival by antagonizing Wnt, ERK and PI3K/Akt signalling. PLoS One (2009) 0.98
The Ser252Trp fibroblast growth factor receptor-2 (FGFR-2) mutation induces PKC-independent downregulation of FGFR-2 associated with premature calvaria osteoblast differentiation. Exp Cell Res (2000) 0.97
LRP5, serotonin, and bone: complexity, contradictions, and conundrums. J Bone Miner Res (2011) 0.96
Spatiotemporal profile of N-cadherin expression in the developing limb mesenchyme. Cell Adhes Commun (1994) 0.95
N- and E-cadherin mediate early human calvaria osteoblast differentiation promoted by bone morphogenetic protein-2. J Cell Physiol (2000) 0.95
Premature osteoblast clustering by enamel matrix proteins induces osteoblast differentiation through up-regulation of connexin 43 and N-cadherin. PLoS One (2011) 0.95
Cellular signaling in developmental chondrogenesis: N-cadherin, Wnts, and BMP-2. J Bone Joint Surg Am (2003) 0.94
Caspase-dependent cleavage of cadherins and catenins during osteoblast apoptosis. J Bone Miner Res (2001) 0.91
Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion. J Bone Miner Res (2005) 0.88
The cadherin cell adhesion receptor family: roles in multicellular organization and neurogenesis. Prog Clin Biol Res (1994) 0.87
N-cadherin adherens junctions mediate osteogenesis through PI3K signaling. Bone (2011) 0.87
Roles of FGFR2 and twist in human craniosynostosis: insights from genetic mutations in cranial osteoblasts. Front Oral Biol (2008) 0.86
Cadherin-dependent cell-cell adhesion. Curr Protoc Cell Biol (2001) 0.84
Peptide-based mediated disruption of N-cadherin-LRP5/6 interaction promotes Wnt signaling and bone formation. J Bone Miner Res (2012) 0.83
Retinoic acid inhibits chondrogenesis of mesenchymal cells by sustaining expression of N-cadherin and its associated proteins. J Cell Biochem (2003) 0.81
Expression of N-cadherin and alkaline phosphatase in chick limb bud mesenchymal cells: regulation by 1,25-dihydroxyvitamin D3 or TGF-beta 1. Exp Cell Res (1994) 0.81
Application of functional blocking antibodies. N-cadherin and chick embryonic limb development. Methods Mol Biol (2000) 0.80
Cadherin-6 mediates the heterotypic interactions between the hemopoietic osteoclast cell lineage and stromal cells in a murine model of osteoclast differentiation. J Cell Biol (1998) 0.80
Expression of the cell adhesion molecule E-cadherin by the human bone marrow stromal cells and its probable role in CD34(+) stem cell adhesion. Cell Biol Int (1998) 0.80
TNF-alpha and IL-1beta suppress N-cadherin expression in MC3T3-E1 cells. J Bone Miner Res (1999) 0.80
N-cadherin expression during periodontal ligament cell differentiation in vitro. J Periodontol (1999) 0.80
Differential regulation of cadherins by dexamethasone in human osteoblastic cells. J Cell Biochem (2000) 0.79
Cadherin-mediated cell-cell interactions. Methods Mol Biol (2000) 0.79
Age-related changes in the expression of cadherin-11, the mesenchyme specific calcium-dependent cell adhesion molecule. Calcif Tissue Int (1998) 0.78
Protein kinase C-dependent upregulation of N-cadherin expression by phorbol ester in human calvaria osteoblasts. Exp Cell Res (2001) 0.78
Integration of cellular adhesion and Wnt signaling: Interactions between N-cadherin and LRP5 and their role in regulating bone mass. J Bone Miner Res (2012) 0.77
The organization of adherens junctions in mouse osteoblast-like cells (MC3T3-E1) and their modulation by triiodothyronine and 1,25-dihydroxyvitamin D3. Histochem Cell Biol (2000) 0.77
Loss of the retinoblastoma tumor suppressor protein in murine calvaria facilitates immortalization of osteoblast-adipocyte bipotent progenitor cells characterized by low expression of N-cadherin. Mol Cell Biol (2012) 0.76
Inhibition of bone resorption in vitro by a peptide containing the cadherin cell adhesion recognition sequence HAV is due to prevention of sealing zone formation. Exp Cell Res (1998) 0.75
Intravenous ibandronate injections in postmenopausal women with osteoporosis: one-year results from the dosing intravenous administration study. Arthritis Rheum (2006) 2.82
Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass. Arch Intern Med (2005) 2.60
Increased prevalence of celiac disease and need for routine screening among patients with osteoporosis. Arch Intern Med (2005) 2.52
Depression, antidepressants, and bone health in older adults: a systematic review. J Am Geriatr Soc (2014) 2.08
Low peak bone mass and attenuated anabolic response to parathyroid hormone in mice with an osteoblast-specific deletion of connexin43. J Cell Sci (2006) 2.06
Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J Cell Biochem (2005) 1.69
JAK inhibition with tofacitinib suppresses arthritic joint structural damage through decreased RANKL production. Arthritis Rheum (2012) 1.67
Osteoblast connexin43 modulates skeletal architecture by regulating both arms of bone remodeling. Mol Biol Cell (2011) 1.63
The conditional connexin43G138R mouse mutant represents a new model of hereditary oculodentodigital dysplasia in humans. Hum Mol Genet (2007) 1.61
Gap junctions in skeletal development and function. Biochim Biophys Acta (2005) 1.53
Attenuated response to in vivo mechanical loading in mice with conditional osteoblast ablation of the connexin43 gene (Gja1). J Bone Miner Res (2008) 1.51
Gap junctional communication modulates gene transcription by altering the recruitment of Sp1 and Sp3 to connexin-response elements in osteoblast promoters. J Biol Chem (2003) 1.50
Deletion of connexin43 in osteoblasts/osteocytes leads to impaired muscle formation in mice. J Bone Miner Res (2015) 1.50
One-year effects of vitamin D and calcium supplementation on chronic periodontitis. J Periodontol (2010) 1.49
Effects of dietary calcium compared with calcium supplements on estrogen metabolism and bone mineral density. Am J Clin Nutr (2007) 1.49
Targeted expression of a dominant-negative N-cadherin in vivo delays peak bone mass and increases adipogenesis. J Cell Sci (2004) 1.49
Bone turnover in bone biopsies of patients with low-energy cortical fractures receiving bisphosphonates: a case series. Calcif Tissue Int (2009) 1.41
Cross-sectional study of vitamin D and calcium supplementation effects on chronic periodontitis. J Periodontol (2009) 1.40
ErbB3 silencing reduces osteosarcoma cell proliferation and tumor growth in vivo. Gene (2013) 1.38
Gap junctions regulate extracellular signal-regulated kinase signaling to affect gene transcription. Mol Biol Cell (2004) 1.33
N-cadherin in osteolineage cells is not required for maintenance of hematopoietic stem cells. Blood (2012) 1.33
Osteoblastic N-cadherin is not required for microenvironmental support and regulation of hematopoietic stem and progenitor cells. Blood (2012) 1.30
N-cadherin and cadherin 11 modulate postnatal bone growth and osteoblast differentiation by distinct mechanisms. J Cell Sci (2010) 1.26
A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis. Clin Exp Metastasis (2004) 1.23
Single nucleotide polymorphisms in the P2X7 gene are associated to fracture risk and to effect of estrogen treatment. Pharmacogenet Genomics (2007) 1.23
Connexin43 deficiency reduces the sensitivity of cortical bone to the effects of muscle paralysis. J Bone Miner Res (2011) 1.23
FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression. FASEB J (2008) 1.23
Efficacy and tolerability of intravenous ibandronate injections in postmenopausal osteoporosis: 2-year results from the DIVA study. J Rheumatol (2008) 1.18
Intercellular calcium signaling occurs between human osteoblasts and osteoclasts and requires activation of osteoclast P2X7 receptors. J Biol Chem (2001) 1.15
Bone loss after temporarily induced muscle paralysis by Botox is not fully recovered after 12 weeks. Ann N Y Acad Sci (2007) 1.09
Cell-cell adhesion and signaling through cadherins: connecting bone cells in their microenvironment. J Bone Miner Res (2006) 1.08
Safety considerations with bisphosphonates for the treatment of osteoporosis. Drug Saf (2007) 1.08
Accentuated ovariectomy-induced bone loss and altered osteogenesis in heterozygous N-cadherin null mice. J Bone Miner Res (2006) 1.05
Tibial loading increases osteogenic gene expression and cortical bone volume in mature and middle-aged mice. PLoS One (2012) 1.05
Connexin-43 in the osteogenic BM niche regulates its cellular composition and the bidirectional traffic of hematopoietic stem cells and progenitors. Blood (2012) 1.05
Activation of L-type calcium channels is required for gap junction-mediated intercellular calcium signaling in osteoblastic cells. J Biol Chem (2002) 1.04
Enhanced periosteal and endocortical responses to axial tibial compression loading in conditional connexin43 deficient mice. PLoS One (2012) 1.03
Maintaining the trust of physicians and the public in the medical literature: report of a task force on scientific publishing of clinical trials. J Bone Miner Res (2007) 1.03
Calcium sensing receptor-dependent and receptor-independent activation of osteoblast replication and survival by strontium ranelate. J Cell Mol Med (2009) 1.03
Cell-to-cell interactions in bone. Biochem Biophys Res Commun (2005) 1.02
Cell-cell interactions in regulating osteogenesis and osteoblast function. Birth Defects Res C Embryo Today (2005) 1.02
Essential role of nuclear factor of activated T cells (NFAT)-mediated Wnt signaling in osteoblast differentiation induced by strontium ranelate. J Biol Chem (2010) 1.00
Development of mice with osteoblast-specific connexin43 gene deletion. Cell Commun Adhes (2003) 1.00
Constitutively activated NLRP3 inflammasome causes inflammation and abnormal skeletal development in mice. PLoS One (2012) 0.98
Heterogeneous nuclear ribonucleoprotein K represses transcription from a cytosine/thymidine-rich element in the osteocalcin promoter. Biochem J (2005) 0.97
Bisphosphonates improve trabecular bone mass and normalize cortical thickness in ovariectomized, osteoblast connexin43 deficient mice. Bone (2012) 0.96
Microfibril-associated glycoprotein-1, an extracellular matrix regulator of bone remodeling. J Biol Chem (2010) 0.94
Genomic approaches to identifying transcriptional regulators of osteoblast differentiation. Genome Biol (2003) 0.93
Anti-inflammatory properties of a novel N-phenyl pyridinone inhibitor of p38 mitogen-activated protein kinase: preclinical-to-clinical translation. J Pharmacol Exp Ther (2009) 0.92
Murine Frizzled-1 behaves as an antagonist of the canonical Wnt/beta-catenin signaling. J Biol Chem (2003) 0.92
Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma. Cancer Res (2007) 0.91
Patient satisfaction in postmenopausal women treated with a weekly bisphosphonate transitioned to once-monthly ibandronate. J Womens Health (Larchmt) (2009) 0.91
Molecular mechanisms of osteoblast/osteocyte regulation by connexin43. Calcif Tissue Int (2013) 0.91
Role of connexin43 in osteoblast response to physical load. Ann N Y Acad Sci (2006) 0.90
Novel insights into the cellular mechanisms of the anti-inflammatory effects of NF-kappaB essential modulator binding domain peptides. J Biol Chem (2010) 0.89
Dominant negative N-cadherin inhibits osteoclast differentiation by interfering with beta-catenin regulation of RANKL, independent of cell-cell adhesion. J Bone Miner Res (2005) 0.88
Osteoclasts-Key Players in Skeletal Health and Disease. Microbiol Spectr (2016) 0.88
Strontium ranelate rebalances bone marrow adipogenesis and osteoblastogenesis in senescent osteopenic mice through NFATc/Maf and Wnt signaling. Aging Cell (2012) 0.87
Genetic variation in the serotonin transporter and HTR1B receptor predicts reduced bone formation during serotonin reuptake inhibitor treatment in older adults. World J Biol Psychiatry (2013) 0.87
High Wnt signaling represses the proapoptotic proteoglycan syndecan-2 in osteosarcoma cells. Cancer Res (2010) 0.86
The F508del mutation in cystic fibrosis transmembrane conductance regulator gene impacts bone formation. Am J Pathol (2012) 0.85
Selective inducible microsomal prostaglandin E(2) synthase-1 (mPGES-1) inhibitors derived from an oxicam template. Bioorg Med Chem Lett (2010) 0.85
Relationships between clinical attachment level and spine and hip bone mineral density: data from healthy postmenopausal women. J Periodontol (2002) 0.85
Weightlessness and skeleton homeostasis. Hormones (Athens) (2006) 0.84
Calpain-6 is an endothelin-1 signaling dependent protective factor in chemoresistant osteosarcoma. Int J Cancer (2011) 0.83
Embryonic ablation of osteoblast Smad4 interrupts matrix synthesis in response to canonical Wnt signaling and causes an osteogenesis-imperfecta-like phenotype. J Cell Sci (2013) 0.83
Growth factors and bone formation in osteoporosis: roles for fibroblast growth factor and transforming growth factor beta. Curr Pharm Des (2004) 0.82
Dual involvement of protein kinase C delta in apoptosis induced by syndecan-2 in osteoblasts. J Cell Biochem (2006) 0.82
Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice. J Bone Miner Res (2012) 0.82
A new concept for bisphosphonate therapy: a rationale for the development of monthly oral dosing of ibandronate. Osteoporos Int (2005) 0.82
Different sympathetic pathways control the metabolism of distinct bone envelopes. Bone (2012) 0.81
Postnatal ablation of osteoblast Smad4 enhances proliferative responses to canonical Wnt signaling through interactions with β-catenin. J Cell Sci (2013) 0.81
Critical role for apoptosis signal-regulating kinase 1 in the development of inflammatory K/BxN serum-induced arthritis. Int Immunopharmacol (2010) 0.81
N-cadherin restrains PTH activation of Lrp6/β-catenin signaling and osteoanabolic action. J Bone Miner Res (2015) 0.80
The oxidative metabolism of estrogen modulates response to ERT/HRT in postmenopausal women. Bone (2004) 0.80
Repression of osteoblast maturation by ERRα accounts for bone loss induced by estrogen deficiency. PLoS One (2013) 0.80
The pro-osteogenic action of beta-catenin requires interaction with BMP signaling, but not Tcf/Lef transcriptional activity. J Cell Biochem (2008) 0.79
The pattern of alveolar crest height change in healthy postmenopausal women after 3 years of hormone/estrogen replacement therapy. J Periodontol (2002) 0.79
Estrogen and/or calcium plus vitamin D increase mandibular bone mass. J Periodontol (2004) 0.79
Risedronate increases osteoblastic differentiation and function through connexin43. Biochem Biophys Res Commun (2013) 0.79
Cell-cell signaling: broadening our view of the basic multicellular unit. Calcif Tissue Int (2013) 0.79
Apoptosis in membranous bone formation: role of fibroblast growth factor and bone morphogenetic protein signaling. Crit Rev Eukaryot Gene Expr (2005) 0.79
Low-magnitude whole-body vibration does not enhance the anabolic skeletal effects of intermittent PTH in adult mice. J Orthop Res (2010) 0.78
A new selective estrogen receptor modulator, CHF 4227.01, preserves bone mass and microarchitecture in ovariectomized rats. J Bone Miner Res (2005) 0.78
Renal effects induced by prolonged mPGES1 inhibition. Am J Physiol Renal Physiol (2013) 0.76
Targeting the E3 ubiquitin casitas B-lineage lymphoma decreases osteosarcoma cell growth and survival and reduces tumorigenesis. J Bone Miner Res (2012) 0.76
Expression, purification and functional characterization of IkappaB kinase-2 (IKK-2) mutants. Protein Expr Purif (2010) 0.76
Casting new light on the sunshine vitamin. Calcif Tissue Int (2013) 0.75